Test strips MicroalbuPHAN® and MicroalbuPHAN® LAURA

The detection of low concentrations of albumin in urine may indicate a risk of early kidney damage. Microalbuminuria is the first sign of potential nephropathy or other complications associated with diabetes mellitus. It is also a strong risk factor for cardiovascular disease and, in relation to the risk of high blood pressure, an early marker of complications in diabetic pregnancies.
 

A diagnostic test strip for the visual assessment of microalbuminuria, manufactured by Erba Lachema s.r.o., has been available for several years and has established its place particularly in diabetic specialists’ laboratories. The strip for objective evaluation, used in combination with the LAURA Smart urine reader, eliminates potential errors that may occur during visual assessment. The resulting measurements are more accurate and reliable, while significantly improving user convenience.
 

Both analytes, creatinine and microalbumin, are evaluated, as well as their ratio, which is the clinically most important result. The urine albumin test is based on the colour change of an acid-base indicator. The urine creatinine test is based on the reaction of creatinine with 3,5-dinitrobenzoic acid in an alkaline environment. The calculated albumin-to-creatinine ratio can be expressed in either mg/mmol or mg/g.
 

The MicroAlbuPHAN^® LAURA diagnostic test strip contains a compensation zone designed to eliminate the influence of urine colour. Dark-coloured urine may adversely affect result evaluation and lead to false-positive results. With PHAN^® LAURA test strips, however, this effect is eliminated by the compensation zone, which functions as a blank.
 

MicroAlbuPHAN^® LAURA diagnostic test strips, in combination with the LAURA Smart urine reader, offer a simple and convenient solution for determining microalbuminuria in urine.